Literature DB >> 29208392

Concordance between plasma-based and tissue-based next-generation sequencing in LOTUS.

Sung-Bae Kim1, Rebecca Dent2, Matthew J Wongchenko3, Stina M Singel3, José Baselga4.   

Abstract

Mesh：

Year:  2017        PMID： 29208392     DOI： 10.1016/S1470-2045(17)30785-4

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  3 in total

Review 1.  Biomarkers in Triple-Negative Breast Cancer: State-of-the-Art and Future Perspectives.

Authors:  Stefania Cocco; Michela Piezzo; Alessandra Calabrese; Daniela Cianniello; Roberta Caputo; Vincenzo Di Lauro; Giuseppina Fusco; Germira di Gioia; Marina Licenziato; Michelino De Laurentiis
Journal:  Int J Mol Sci       Date:  2020-06-27       Impact factor: 5.923

2.  HER2 genomic amplification in circulating tumor DNA and estrogen receptor positivity predict primary resistance to trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer.

Authors:  Hitomi Sakai; Junji Tsurutani; Tsutomu Iwasa; Yoshifumi Komoike; Kazuko Sakai; Kazuto Nishio; Kazuhiko Nakagawa
Journal:  Breast Cancer       Date:  2018-04-26       Impact factor: 4.239

3.  ctDNA facilitated the diagnosis of a patient with synchronous urothelial carcinoma and non-small cell lung cancer: case report.

Authors:  Chengyuan Qian; Nan Dai; Mingfang Xu; Hao Luo; Yan Feng; Min Zhang; Rongrong Chen; Dong Wang
Journal:  Ann Transl Med       Date:  2020-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.